AEHR holder plans sale of 2,000 common shares
A shareholder of AEHR Test Systems filed a notice of proposed sale of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
A shareholder of AEHR Test Systems filed a notice of proposed sale of common stock. The filing lists 2,000 shares of common stock to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with a reported value of $201,916.91.
The notice also identifies underlying sources of these shares as restricted stock awards, including 235 shares scheduled to vest on April 27, 2026 and 1,765 shares scheduled to vest on July 1, 2026, both described as compensation.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Vesting financial
compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does AEHR's Form 144 filing disclose about planned stock sales?
Which broker is handling the proposed AEHR (AEHR) stock sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.